FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum
APLLTD Share Price Target
Alembic Pharmaceuticals Ltd.
Sector: Pharmaceuticals and health care
Sector: Pharmaceuticals and health care
APLLTD Share Price *
550.6 -8.85 (-1.58%)
* (quote may be delayed)
APLLTD Share Price Forecast - Consensus
| No. of reports in last year | 7 |
| No. of analysts | 5 |
| Average Consensus Forecast | 616.86 |
| Consensus Potential | 8.92% |
APLLTD Share Price Target - Broker Reports - 2019
YES Securities
24-Oct-19
Price @ Call: 545.77
Target: 600
BUY
Alembic would start expensing derma facility from Q3 even as another Rs5bn capex is still to be incurred in current fiscal. Cumulative capex including pre-operative expenditure is Rs15bn till date and we reckon company can achieve stated goal of US$450-500mn US sales over next few years. In domestic business, encouragingly, prescriptions and number of prescribers have expanded which rules out any structural concern behind no growth yoy in H1. While we remain convinced earnings growth would accelerate beyond FY21, even so H1 US performance has held the fort in the interim. Our ADD rating stays with unchanged 1-year TP of Rs600, as growth will follow a huge investment phase that should end in the current fiscal.
ICICIdirect.com
1-Aug-19
Price @ Call: 520.28
Target: 540
HOLD
Q1 revenues were mainly driven by strong growth in the US. The company also reported one of the strongest gross margin performances although as the management asserted, these are unsustainable. Overall, US growth remains strong but opportunistic whereas India growth remains slightly insipid. With the aggressive R&D and capex, the management has signalled its long term strategy for the next five to six years, especially on the US front. This includes a foray into niche areas like oncology, injectables, derma, etc. We believe this is fraught with a new set of challenges. The benefits are most likely to be back-loaded. Immediate cash burn is likely to weigh on sentiments in the near term. Our target price arrives at Rs540 based on 22x FY21E EPS of Rs 25.4.
IIFL
12-Jul-19
Price @ Call: 541.12
Target: 675
BUY
Motilal Oswal
20-Mar-19
Price @ Call: 541.18
Target: 615
NEUTRAL
We expect 9% earnings CAGR over FY19-21, which appears moderate, partly due to the high base of FY19. We further expect earnings momentum to improve greatly, FY21 onwards, as ALPM starts reaping benefits from its new investments. We value ALPM at 18x 12M forward earnings and arrive at a PT of INR615. We remain positive on ALPM, on the back of its strong product pipeline in onco injectables/ derma/ oral solids dosages, creation of capacity/capability to support manufacturing and for its sound compliance record in the US market. Even the domestic branded formulation business is in good stead to outperform the industry. However, we maintain Neutral on limited upside from current levels.
Motilal Oswal
23-Jan-19
Price @ Call: 587.8
Target: 615
ACCUMULATE
Karvy Stock Broking
23-Jan-19
Price @ Call: 587.8
Target: 653
HOLD
ICICIdirect.com
23-Jan-19
Price @ Call: 587.8
Target: 620
HOLD
APLLTD Share Price Target - Broker Reports - 2018
HDFC Securities
23-Oct-18
Price @ Call: 580.05
Target: 610
BUY
JM Financial
30-Jul-18
Price @ Call: 556.65
Target: 570
ACCUMULATE
Motilal Oswal
17-May-18
Price @ Call: 479.25
Target: 500
NEUTRAL
JM Financial
17-May-18
Price @ Call: 478.67
Target: 570
BUY
Indiabulls Ventures
10-Jan-18
Price @ Call: 556.95
Target: 785
BUY
APLLTD Share Price Target - Broker Reports - 2017
ICICIdirect.com
9-Nov-17
Price @ Call: 513.37
Target: 530
HOLD
ICICIdirect.com
21-Jul-17
Price @ Call: 541
Target: 570
HOLD
KRChoksey
21-Jul-17
Price @ Call: 540
Target: 580
HOLD
HDFC Securities
20-Jul-17
Price @ Call: 552
Target: 635
BUY
Angel Broking
9-May-17
Price @ Call: 593
Target: 648
ACCUMULATE
Axis Direct
9-May-17
Price @ Call: 590
Target: 610
HOLD
Nirmal Bang
5-May-17
Price @ Call: 600
Target: 632
HOLD
ICICIdirect.com
4-May-17
Price @ Call: 597
Target: 605
HOLD
HDFC Securities
3-May-17
Price @ Call: 605
Target: 675
BUY
KRChoksey
27-Jan-17
Price @ Call: 578
Target: 667
ACCUMULATE
APLLTD Share Price Target - Broker Reports - 2016
Nirmal Bang
2-Nov-16
Price @ Call: 665
Target: 732
HOLD
KRChoksey
26-Oct-16
Price @ Call: 678
Target: 690
HOLD
ICICIdirect.com
26-Oct-16
Price @ Call: 678
Target: 700
HOLD
Axis Direct
26-Oct-16
Price @ Call: 673
Target: 700
HOLD
AnandRathi
4-Oct-16
Price @ Call: 657.2
Target: 728
BUY
ICICIdirect.com
18-Jul-16
Price @ Call: 574
Target: 654
BUY
Axis Direct
5-Jul-16
Price @ Call: 584.09
Target: 600
HOLD
AnandRathi
30-Jun-16
Price @ Call: 547
Target: 576
HOLD
Axis Direct
28-Apr-16
Price @ Call: 619
Target: 560
SELL